Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxegol PK and Safety in Pediatric OIC
NCT02099591Phase 1Completed
- Sponsor
- Kyowa Kirin
- Start
- Nov 2014
- Primary completion
- Apr 2021
- Modality
- Metabolically Activated Prodrugs
- Countries
- 5
01
Overview
Phase 1, open-label trial of naloxegol in opioid-induced constipation (OIC) (6 arms), sponsored by Kyowa Kirin. Primary endpoint: Pharmacokinetics of naloxegol after single oral dose at Day 1. Started Nov 2014; status: completed.
02
Drugs
naloxegol
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT02099591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02099591.